Posts

Posted on

Phreesia Announces Proposed Public Offering of Common Stock

Phreesia Announces Proposed Public Offering of Common Stock

RALEIGH, N.C.–(BUSINESS WIRE)–
Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed, or as to the actual size and terms of the offering.

J.P. Morgan and William Blair are acting as joint book-running managers for the Offering and as representatives of the underwriters. Allen & Company LLC and Piper Sandler are acting as passive book-running managers for the Offering.

The Offering will be made only by means of a prospectus supplement and an accompanying prospectus. When available, copies of the preliminary prospectus supplement and accompanying prospectus relating to the Offering may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 1-866-803-9204; or from William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, telephone: 1-800-621-0687.

An automatic shelf registration statement on Form S-3ASR relating to these securities is on file with the Securities and Exchange Commission (the “SEC”) and is effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

ABOUT PHREESIA

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, consistent experience, while enabling healthcare organizations to enhance clinical care and drive efficiency.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release includes express or implied statements that are not historical facts and are considered forward-looking statements within the meaning of Section 27A of the Securities Act, as amended, and Section 21E of the Securities Exchange Act, as amended, including, without limitation, statements concerning our expectations regarding the consummation of the Offering and the terms of the Offering. Forward-looking statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and may contain projections of our future results of operations or of our financial information or state other forward-looking information. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including, without limitation, market risks and uncertainties and the satisfaction of customary closing conditions relating to the Offering, and other risks and uncertainties more fully described in our filings with the SEC, including in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021 that has been filed with the SEC and in the “Risk Factors” section of the preliminary prospectus supplement related to the Offering. The forward-looking statements in this press release speak only as of the date on which the statements are made. We undertake no obligation to update, and expressly disclaim the obligation to update, any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

Forward-looking statements speak only as of the date hereof, and, except as required by law, Phreesia undertakes no obligation to update or revise these forward-looking statements.

Phreesia qualifies all of its forward-looking statements by these cautionary statements.

Investors:

Balaji Gandhi

Phreesia, Inc.

[email protected]

(929) 506-4950

Media:

Maureen McKinney

Phreesia, Inc.

[email protected]

(773) 330-8908

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Technology Hospitals Software Practice Management Networks Managed Care Health General Health Data Management

MEDIA:

Logo
Logo
Posted on

Telos Corporation Completes Follow-On Offering

ASHBURN, Va., April 06, 2021 (GLOBE NEWSWIRE) — Telos® Corporation (“Telos”) (Nasdaq: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, announced today the closing of its follow-on offering (the “Offering”) of 9,090,909 shares of common stock at a price of $33.00 per share, including a secondary public offering of 7,040,909 shares of common stock by certain existing stockholders of Telos (the “Selling Stockholders”). The Offering included a full exercise of the underwriters’ option to purchase additional shares of common stock at the offering price, less underwriting discounts and commissions, to cover over-allotments. After giving effect to the full exercise of the option, the gross proceeds to Telos increased to $64,605,750. Telos did not receive any proceeds from the shares of common stock sold by the Selling Stockholders.

B. Riley Securities, BMO Capital Markets, and Needham & Company acted as joint bookrunners for the offering. D.A. Davidson & Co., Wedbush Securities, Colliers Securities LLC, Northland Capital Markets, and MKM Partners served as co-managers for the Offering.

The shares of common stock described above were offered by Telos and the Selling Stockholders pursuant to a “shelf” registration statement that was filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2021, which was automatically effective upon filing, and a final prospectus supplement.

The Offering has been made only by means of a prospectus. Copies of the final prospectus relating to this Offering may be obtained from: B. Riley Securities, Inc., Attn: Prospectus Department, 1300 North 17th Street, Suite 1300, Arlington, VA 22209, telephone: (703) 312-9580, or by emailing [email protected]; BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036, telephone: (800) 414-3627, or by emailing [email protected]; or Needham & Company, LLC, Attn: Prospectus Department, 250 Park Avenue, 10th Floor, New York, NY 10177, telephone: (800) 903-3268, or by emailing [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Offering. There can be no assurance that Telos will be able to complete the proposed offering of additional shares on the anticipated terms, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Telos, including risks and uncertainties related to the satisfaction of customary closing conditions related to the offering of additional shares and those set forth in the Risk Factors section of Telos’ registration statement for the initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Telos undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

About Telos Corporation


Telos Corporation
 (NASDAQ: TLS) empowers and protects the world’s most security-conscious organizations with solutions for continuous security assurance of individuals, systems, and information. Telos’ offerings include cybersecurity solutions for IT risk management and information security; cloud security solutions to protect cloud-based assets and enable continuous compliance with industry and government security standards; and enterprise security solutions for identity and access management, secure mobility, organizational messaging, and network management and defense. The company serves military, intelligence and civilian agencies of the federal government, allied nations and commercial organizations around the world.

Media:

Mia Wilcox
Merritt Group on behalf of Telos Corporation
Email: [email protected]         
Phone: (610) 564-6773

Investors:

Brinlea Johnson
The Blueshirt Group on behalf of Telos Corporation
[email protected]



Posted on

Cincinnati Financial Schedules Webcast to Discuss First-Quarter 2021 Results

PR Newswire

CINCINNATI, April 6, 2021 /PRNewswire/ — Cincinnati Financial Corporation (Nasdaq: CINF) invites you to listen to the live internet broadcast of its conference call to discuss first-quarter 2021 results on Thursday, April 29, 2021, at 11 a.m. ET. The company plans to release its results on Wednesday, April 28, after the close of regular trading on the Nasdaq Stock Market.


What:          

CINF first-quarter 2021 earnings conference call


When:         

Thursday, April 29, 2021, at 11 a.m. ET


Where:        

Live over the internet.


How:           

Visit www.cinfin.com/investors. Participants are encouraged to go to the website to test your systems for compatibility prior to the time of the call.


Replay:       

A replay of the call will be available at cinfin.com/investors beginning approximately two hours after the completion of the live call.


Contact:     

Stephanie Johnson, 513-870-2768

About the Company: Cincinnati Financial Corporation offers primarily business, home and auto insurance through The Cincinnati Insurance Company and its two standard market property casualty companies. The same local independent insurance agencies that market those policies may offer products of our other subsidiaries, including life insurance, fixed annuities and surplus lines property and casualty insurance. For additional information about the company, please visit cinfin.com.

Also available on the company’s website will be information reconciling any non–GAAP financial measures to be discussed on the conference call.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cincinnati-financial-schedules-webcast-to-discuss-first-quarter-2021-results-301263451.html

SOURCE Cincinnati Financial Corporation

Posted on

Trulieve Brings Medical Cannabis to Dunedin

PR Newswire

The location marks the first dispensary in Dunedin, broadening access to the state’s largest inventory of medical cannabis

TALLAHASSEE, Fla., April 6, 2021 /PRNewswire/ – Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a brand-new Florida dispensary, the Company’s 84th nationwide.

The dispensary furthers Trulieve’s goal of ensuring direct, reliable access to medical cannabis across its home state of Florida. The company’s 79th Florida dispensary joins nearby locations in Tampa, St. Petersburg, and Tarpon Springs and brings direct, in-store access to registered patients in Dunedin for the first time.

In honor of the Company’s brand-new dispensary, all patients — from those new to Trulieve to the dedicated Truliever community — will be eligible for a 25% in-store discount at the new dispensary on opening day.

ANNOUNCING: Trulieve Dunedin Grand Opening 
WHERE: 1846 Main Street, Dunedin, FL 34698
WHEN: Thursday, April 8, 2021, at 9:00 a.m.

In stores and online, patients will find Florida’s largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients and convenient in-store pickup at each of its 79 dispensaries in Florida.

To assist patients with ordering, Trulieve has made the entire catalog of products available for online ordering, with in-store pickup and statewide home delivery options available. Patients can schedule a complimentary 30-minute virtual consultation with a Trulieve certified consultant to help navigate questions on products, devices, or review their doctor’s recommendation.

All visitors are required to wear masks for the duration of their dispensary visit. Only patients and their state-approved caregivers will be allowed inside the waiting room and dispensary at this time.

To assist with CDC recommendations for social distancing and in compliance with additional company-enforced safety guidelines, several measures have been taken to ensure the health and well-being of employees and patients. These include modifications to the layout of all stores, installation of plexiglass partitions and HEPA air filtration scrubbers in every dispensary, increasing access to masks and sanitizer throughout the store for staff and visitors, utilizing visual aids to direct traffic throughout the store, and increasing the frequency of deep cleanings for all dispensaries.

Trulieve is closely monitoring the coronavirus situation and will update store policies as needed to ensure the highest level of safety of our patients and staff. All updates will be shared directly on Trulieve’s website as they are enacted.

The Office of Medical Marijuana Use recently announced the registry has surpassed 520,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling approximately half of the state’s overall volume per the Florida Department of Health. To support the state’s rapidly growing patient base, there are over 2,500 registered ordering physicians in the State of Florida.

For more information, please visit www.Trulieve.com.

About Trulieve 
Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also has operations in California, Massachusetts, Connecticut and Pennsylvania. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

To learn more about Trulieve, visit www.Trulieve.com.

Cision View original content:http://www.prnewswire.com/news-releases/trulieve-brings-medical-cannabis-to-dunedin-301263472.html

SOURCE Trulieve Cannabis Corp.

Posted on

MoneyGram Announces Hilary Jackson as New Chief Operating Officer

Ms. Jackson’s strong track record in technology, innovation, and operations at customer-centric financial services companies will be a significant asset in the next stage of the Company’s digital transformation

PR Newswire

DALLAS, April 6, 2021 /PRNewswire/ — MoneyGram International, Inc. (NASDAQ: MGI), a global leader in cross-border P2P payments and money transfers, today announced the appointment of Hilary Jackson as its new Chief Operating Officer reporting to Alex Holmes, Chairman and CEO. The appointment is effective April 26, 2021.

Ms. Jackson joins MoneyGram from Selene Holdings where she served as Chief Operating Officer. Prior to joining Selene, Ms. Jackson held multiple executive roles at Capital One, including Head of Technology for Top of House Products within Capital One’s Financial Services division, and Head of Home Loans Servicing.  

Hilary also spent 12 years at Bank of America, where she provided executive leadership in the mortgage lines of business. Within mortgage servicing, she led risk assessment and analytics, horizontal business controls, business transformation, strategic implementation, program management, and loss mitigation operations. She also held executive leadership roles within the mortgage originations and sales organizations. 

“We are thrilled to welcome Hilary Jackson as our new Chief Operating Officer,” said Alex Holmes, MoneyGram Chairman and CEO. “As we continue to accelerate our digital transformation, Hilary’s strong track record of success leading technology and operations functions in the financial services sector will be critical to helping MoneyGram continue to lead the evolution of digital P2P payments and mobilize the movement of money.”

About MoneyGram International, Inc.

MoneyGram is leading the evolution of digital P2P payments. With a purpose-driven strategy to mobilize the movement of money, a strong culture of fintech innovation, and leading customer-centric capabilities, MoneyGram has grown to serve nearly 150 million people across the globe over the last five years.

The Company leverages its modern, mobile, and API-driven platform and collaborates with the world’s leading brands to serve consumers through MoneyGram Online (MGO), its direct-to-consumer digital business, its global retail network and its emerging embedded finance business for enterprise customers, MoneyGram as a Service.

For more information, please visit ir.moneygram.com and follow @MoneyGram.

Media Contact

Stephen Reiff

[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/moneygram-announces-hilary-jackson-as-new-chief-operating-officer-301263390.html

SOURCE MoneyGram

Posted on

Alteryx Global Inspire 2021 Conference to Showcase New Products and Innovations in Analytics and Data Science

Luminary Thought Leaders Fareed Zakaria, will.i.am, Billy Beane and DJ Patil Join Alteryx Executives to Headline Inspire 2021

PR Newswire

IRVINE, Calif., April 6, 2021 /PRNewswire/ — Alteryx, Inc. (NYSE: AYX), a leader in analytic process automation (APA™) that automates analytics, data science and processes to accelerate business outcomes, today announced its annual conference, Inspire, will take place May 18-21 and will be broadcasted across the U.S., EMEA and APAC. Virtual Global Inspire 2021, centered around the theme United We Solve, includes participation from thousands of citizen analysts, data scientists and business leaders from across the globe. Luminaries and industry experts will discuss the state of the market, the role of analytics in digital transformation, ethics in artificial intelligence (AI) and the future of analytics and data science in a post-pandemic world.

“Inspire has always been a roaring success, and this year, it will be the biggest global experience we’ve hosted. Our global conference is designed to educate and unite our customers, partners and the global analytics community around our mission — to enable every person to transform data into a breakthrough,” said Mark Anderson, chief executive officer of Alteryx. “This year’s conference will feature numerous innovations, all of which will be focused on enhancing cognitive diversity and fostering collaboration to solve some of the biggest challenges of our time with data science and analytics automation.”

The three-day event centers around several core themes: Innovation to Transformation, Analytics and Data Science Automation for Breakthrough Outcomes and Learning and Community. The event will feature industry-leading voices — global thought leaders, business leaders, data science experts and select Alteryx executives, including:


  • Fareed Zakaria,     journalist, political commentator and author of “Ten Lessons for a Post-Pandemic World”
  • Dr. DJ Patil, former chief data scientist of the United States Office of Science and Technology Policy
  • Dr. Hannah Fry, associate professor in the Mathematics of Cities at the Centre for Advanced Spatial Analysis at University College London
  • will.i.am, musical artist, producer, actor and entrepreneur

  • Billy Beane
    , executive vice president of baseball operations for the Oakland A’s and subject of Moneyball

  • Jake Porway
    , machine learning expert and co-founder and executive director of DataKind
  • Alteryx Executives:
    Mark Anderson, Sharmila Mulligan, Suresh Vittal, Matthew Stauble, Alan Jacobson and Olivia (Libby) Duane Adams

“Inspire is the premiere analytics automation event that brings together organizations and people of all skillsets to leverage analytics and data science for transformational business outcomes,” said Sharmila Mulligan, chief strategy and marketing officer of Alteryx. “This year, we will announce major innovations across analytics automation, data science, machine learning and AI and the Alteryx Community platform. Attendees will also hear from Alteryx customers and a host of new strategic partners that are an integral part of our fast-growing partner ecosystem.”

Across three days and 100-plus product and innovation sessions, thousands of global attendees will come together to learn and share successes and solutions geared toward improving the global economy and society. The event also includes training and product sessions, interstitial segments, a live news desk and the Alteryx Grand Prix, a highly popular competition designed for the most advanced Alteryx users who will compete to solve a series of analytics challenges.

For more information about Virtual Global Inspire 2021, please visit inspire.alteryx.com and please register here to attend.

About Alteryx

As a leader in analytic process automation (APA™), Alteryx unifies analytics, data science and business process automation in one, end-to-end platform to accelerate digital transformation. Organizations of all sizes, all over the world, rely on the Alteryx Analytic Process Automation Platform™ to deliver high-impact business outcomes and the rapid upskilling of their modern workforce. For more information visit www.alteryx.com.

Alteryx is a registered trademark of Alteryx, Inc. All other product and brand names may be trademarks or registered trademarks of their respective owners.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/alteryx-global-inspire-2021-conference-to-showcase-new-products-and-innovations-in-analytics-and-data-science-301263389.html

SOURCE Alteryx, Inc.

Posted on

Cimarex Schedules First-Quarter 2021 Results Conference Call for Thursday, May 6, 2021

PR Newswire

DENVER, April 6, 2021 /PRNewswire/ — Cimarex Energy Co. (NYSE: XEC) will host a conference call on Thursday, May 6, 2021, at 9:00 AM MT (11:00 AM ET) to discuss first-quarter 2021 financial and operating results. The Company plans to announce first-quarter 2021 results on Wednesday, May 5, 2021, after close of trading.

A live audio webcast of the presentation will be available on the “Events & Presentations” page under the “Investor Relations” section of the Company’s website at www.cimarex.com. The webcast will be archived and available at the same location after the conclusion of the live event.

Conference Call Information
Dial-in (for callers in the U.S.): (866) 367-3053
Dial-in (for callers in Canada): (855) 669-9657
Intl. dial-in: (412) 902-4216

Cimarex Energy 

Denver-based Cimarex Energy Co. is an independent oil and gas exploration and production company with principal operations in the Permian Basin and Mid-Continent areas of the U.S. For more information about Cimarex, visit www.cimarex.com.

 

Cision View original content:http://www.prnewswire.com/news-releases/cimarex-schedules-first-quarter-2021-results-conference-call-for-thursday-may-6-2021-301263315.html

SOURCE Cimarex Energy Co.

Posted on

RPC, Inc. Announces Date for First Quarter 2021 Financial Results and Conference Call

PR Newswire

ATLANTA, April 6, 2021 /PRNewswire/ — RPC, Inc. (NYSE: RES) announced today that it will release its financial results for the first quarter ended March 31, 2021 on Wednesday, April 28, 2021 before the market opens.  In conjunction with its earnings release, the Company will host a conference call to review the Company’s financial and operating results on Wednesday, April 28, 2021 at 9:00 a.m. Eastern Time.

RPCBlueLogo

Individuals wishing to participate in the conference call should dial toll-free (833) 579-0910 or (778) 560-2620 for international callers, and use conference ID number 3471295.  For interested individuals unable to join by telephone, the call also will be broadcast and archived for 90 days on the Company’s investor website.  Interested parties are encouraged to click on the webcast link 10-15 minutes prior to the start of the conference call.

RPC provides a broad range of specialized oilfield services and equipment primarily to independent and major oilfield companies engaged in the exploration, production and development of oil and gas properties throughout the United States, including the Gulf of Mexico, mid-continent, southwest, Appalachian and Rocky Mountain regions, and in selected international markets.  RPC’s investor website can be found on the internet at RPC.net.

For information about RPC, Inc. or this event, please contact:

Ben M. Palmer

Chief Financial Officer
(404) 321-2140
[email protected]

Jim Landers

Vice President Corporate Services
(404) 321-2162
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/rpc-inc-announces-date-for-first-quarter-2021-financial-results-and-conference-call-301263463.html

SOURCE RPC, Inc.

Posted on

Dominion Energy Schedules First-Quarter 2021 Earnings Call

PR Newswire

RICHMOND, Va., April 6, 2021 /PRNewswire/ — Dominion Energy, Inc. (NYSE: D) will host its first-quarter 2021 earnings call at 10 a.m. ET on Tuesday, May 4, 2021.  Management will discuss matters of interest to financial and other stakeholders including recent financial results.    

A live webcast of the conference call, including accompanying slides and other financial information, will be available on the investor information pages at investors.dominionenergy.com.

For individuals that prefer to join via telephone, domestic callers should dial 1-800-341-6228 and international callers should dial 1-334-777-6993.  The passcode for the telephonic earnings call is 46791738#.  Participants should dial in 10 to 15 minutes prior to the scheduled start time. 

A replay of the webcast will be available on the investor information pages by the end of the day May 4.  A telephonic replay of the earnings call will be available beginning at about 1 p.m. ET on May 4.  Domestic callers may access the recording by dialing 1-877-919-4059.  International callers should dial 1-334-323-0140.  The PIN for the replay is 38488843.


About Dominion Energy

More than 7 million customers in 16 states energize their homes and businesses with electricity or natural gas from Dominion Energy (NYSE: D), headquartered in Richmond, Va. The company is committed to sustainable, reliable, affordable and safe energy and to achieving net zero carbon dioxide and methane emissions from its power generation and gas infrastructure operations by 2050. Please visit DominionEnergy.com to learn more. 

Cision View original content:http://www.prnewswire.com/news-releases/dominion-energy-schedules-first-quarter-2021-earnings-call-301263057.html

SOURCE Dominion Energy

Posted on

Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021

PR Newswire

TARRYTOWN, N.Y., April 6, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2021 financial and operating results on Thursday, May 6, 2021, before the U.S. financial markets open.  The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.

Conference Call Information
To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7794757. A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http://investor.regeneron.com/events.cfm. A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days. 

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.

Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:
Investor Relations
Justin Holko
914.847.7786
[email protected]

Corporate Communications
Hala Mirza
914.847.3422
[email protected]

 

Cision View original content:http://www.prnewswire.com/news-releases/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021-301263387.html

SOURCE Regeneron Pharmaceuticals